Who Owns Baxano Surgical, Inc.
Oak Point Partners acquired the remnant assets of the Baxano Liquidation Trust (Baxano) in December 2017.
On November 12, 2014, Baxano filed a voluntary chapter 11 petition in the United States Bankruptcy Court for the District of Delaware, assigned Case No. 14-12545. On July 24, 2015, the Court entered an order confirming the Debtor’s Second Amended Chapter 11 Plan of Reorganization, pursuant to which the Trust was created and vested with the power and duty to administer the remaining assets of the Debtor. Oak Point Partners acquired the remnant assets of the Baxano Liquidation Trust in December 2017.
Related Entities: Trans1, Inc.
Contact Information Regarding Payments to Baxano Surgical, Inc.
Inquiries regarding where to send: Overpayments, Undeliverable Funds, Insurance Refunds, Refunds, Warrants, Unclaimed Funds, Rebates, Uncashed Checks, Restitution, Credit Balance, Escheat, Judgment Balance, Abandoned Property, Settlement Proceeds, or any other funds belonging to Baxano Surgical, Inc..
Requests for reasonable referral or finder fees will be considered.
Contact Info: Baxano Surgical, Inc.
About Baxano Surgical, Inc.
Baxano was a medical device company that developed, manufactured, and marketed minimally-invasive products to treat degenerative conditions of the spine.
Baxano also operated as Trans1, Inc.
The former headquarters of Baxano was located in Raleigh, NC. The company also had a corporate address in Wilmington, NC.